Publication Date
4-1-2022
Journal
Clinical Gastroenterology and Hepatology
DOI
10.1016/j.cgh.2021.04.008
PMID
33839273
PMCID
PMC8900254
PubMedCentral® Posted Date
4-1-2022
PubMedCentral® Full Text Version
Author MSS
Published Open-Access
yes
Keywords
Adenocarcinoma, Barrett Esophagus, Disease Progression, Endoscopy, Gastrointestinal, Esophageal Neoplasms, Humans, Prevalence, Retrospective Studies, Veterans, Barrett’s esophagus, esophageal adenocarcinoma, missed dysplasia, dysplasia rate, incidence, risk factors
Abstract
BACKGROUND & AIMS: Limitations of endoscopic sampling may result in missed dysplasia at the diagnosis of Barrett's esophagus (BE). However, the role of close follow-up endoscopy is unclear. The aim was to evaluate the proportion of patients diagnosed with "missed" dysplasia within 18 months of their index nondysplastic BE (NDBE) diagnosis.
METHODS: This was a retrospective analysis of a cohort of BE patients diagnosed during 1990-2019 at the Houston VA. Patients with BE on index esophagogastroduodenoscopy (EGD) were classified as NDBE, indefinite dysplasia, or dysplastic (low- or high-grade dysplasia) based on initial biopsies. We identified NDBE patients who had follow-up EGD within 3-18 months after index EGD. We used logistic regression models to estimate odds ratios and 95% confidence intervals for risk factors of dysplasia on follow-up EGD.
RESULTS: We identified 614 patients who had BE on index EGD. Among those with NDBE and follow-up EGD within 3-18 months (n = 271), 4.1% had definite dysplasia on follow-up, and an additional 14.0% had indefinite dysplasia. Proportions of definite or indefinite dysplasia at follow-up within 3-18 months significantly decreased from 32.6% among patients with index EGD before 2009 to 11.7% among patients with index EGD after 2013 (P for trend = .068). Those with any indefinite or definite dysplastic BE at follow-up within 3-18 months after index EGD (n = 49) were more likely to have BE length ≥3 cm on index EGD (odds ratio, 3.39; 95% confidence interval, 1.63-7.08) than those with persistent NDBE or no BE on follow-up.
CONCLUSIONS: The occurrence of missed dysplasia on an index EGD has decreased over time. However, those with long segment BE were more than 3 times as likely to have missed dysplasia, and this group could benefit from dysplasia surveillance within 18 months of BE diagnosis.
Included in
Biochemistry, Biophysics, and Structural Biology Commons, Biology Commons, Digestive System Diseases Commons, Gastroenterology Commons, Medical Sciences Commons
